Back to Gastroenterology
Gastroenterologyv2008Evidence-Based

United Kingdom Model for End-Stage Liver Disease (UKELD)

Predicts mortality in end-stage liver disease patients for liver transplant planning. Developed specifically for UK population to determine eligibility for liver transplantation and estimate patient prognosis.

Clinical Input Parameters

ratio
Range: 0.8 — 10 ratio
µmol/L
Range: 30 — 800 µmol/L
µmol/L
Range: 5 — 1000 µmol/L
mmol/L
Range: 120 — 150 mmol/L
Clinical Assessment
Awaiting Parameters
ukeld score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The United Kingdom Model for End-Stage Liver Disease (UKELD) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within gastroenterology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

UKELD Score = 5.395 × ln(INR) + 1.485 × ln(creatinine, µmol/L) + 3.13 × ln(bilirubin, µmol/L) - 81.565 × ln(sodium, mmol/L) + 435

Clinical Pearls & Practice Notes

  • Developed specifically for the UK population based on data from UK liver transplantation centers (2003-2007)
  • Score ≥49 is the cutoff for transplant eligibility in the UK, corresponding to >9% 1-year mortality without transplantation
  • Score of 60 predicts approximately 50% 1-year mortality without transplantation
  • Excludes patients with hepatocellular carcinoma, who may qualify for transplantation through other criteria
  • Interlaboratory differences in laboratory values may affect score accuracy
  • Based on natural logarithm calculations - ensure all laboratory values are positive and within physiological ranges
  • Used in conjunction with clinical assessment and other factors to determine transplant candidacy
  • Originally derived from the MELD score but incorporates serum sodium and uses UK-specific coefficients

Evidence & Literature Citations

  1. Neuberger J, Gimson A, Davies M, Akyol M, O'Grady J, Burroughs A, Hudson M. Selection of patients for liver transplantation and allocation of donated livers in the UK. Gut. 2008;57(2):252-7.
  2. Barber K, Madden S, Allen J, Collett D, Neuberger J, Gimson A. Elective liver transplant list mortality: development of a United Kingdom end-stage liver disease score. Transplantation. 2011;92(4):469-76.

Score Interpretation Ranges

Below Transplant Threshold0 – 48 pts

Low mortality risk

Transplant Eligible49 – 59 pts

Moderate to high mortality risk

High Priority Transplant60 – 100 pts

Very high mortality risk

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.